{"id":"NCT00090103","sponsor":"GlaxoSmithKline","briefTitle":"Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment","officialTitle":"A Randomized, Double-blind, Parallel Group Study to Investigate the Efficacy and Safety of Treatment With Dutasteride (0.5mg) and Tamsulosin (0.4mg), Administered Once Daily for 4 Years, Alone and Combination, on the Improvement of Symptoms and Clinical Outcome in Men With Moderate to Severe Symptomatic Benign Prostatic Hyperplasia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-11","primaryCompletion":"2009-04","completion":"2009-04","firstPosted":"2004-08-26","resultsPosted":"2010-03-16","lastUpdate":"2017-02-28"},"enrollment":4844,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Prostatic Hyperplasia"],"interventions":[{"type":"DRUG","name":"dutasteride 0.5mg once daily for 4 years","otherNames":[]},{"type":"DRUG","name":"tamsulosin 0.4mg once daily for 4 years","otherNames":["dutasteride","tamsulosin"]}],"arms":[{"label":"dutasteride","type":"ACTIVE_COMPARATOR"},{"label":"Combo","type":"EXPERIMENTAL"},{"label":"tamsulosin","type":"ACTIVE_COMPARATOR"}],"summary":"This study will investigate the efficacy and safety of treatment with dutasteride and tamsulosin, administered once daily for 4 years, alone and in combination, on the improvement of symptoms and clinical outcome in men with moderate to severe symptomatic Benign Prostatic Hyperplasia (BPH). Study visits are every 3 months for up to 4 years (18 clinic visits). Transrectal ultrasound (TRUS) is done annually.","primaryOutcome":{"measure":"Number of Events of Acute Urinary Retention (AUR) or Benign Prostatic Hyperplasia (BPH)-Related Prostatic Surgery at the Indicated Time Periods.","timeFrame":"Years 1, 2, 3, and 4","effectByArm":[{"arm":"Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg","deltaMin":29,"sd":null},{"arm":"Dutasteride 0.5 mg","deltaMin":27,"sd":null},{"arm":"Tamsulosin 0.4 mg","deltaMin":40,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.18"},{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"50 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":25},"locations":{"siteCount":503,"countries":["United States","Argentina","Belgium","Brazil","Bulgaria","Canada","Czechia","Denmark","Estonia","Finland","France","Germany","Greece","Hungary","Iceland","Israel","Italy","Lithuania","Mexico","Netherlands","Norway","Philippines","Poland","Portugal","Puerto Rico","Romania","Russia","Slovakia","South Africa","South Korea","Spain","Taiwan","Thailand","Tunisia","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["21269736","19239460","21933326","19545384","18813219","19825505","21093145","21332630","22425127","19901936","21348912","20487046","21502969","18082216"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":303,"n":1610},"commonTop":["Erectile dysfunction","Hypertension","Nasopharyngitis","Back pain","Influenza"]}}